CSat Investment Advisory’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$11K Buy
52
+2
+4% +$394 0.01% 437
2020
Q4
$9K Sell
50
-10,379
-100% -$1.77M 0.01% 437
2020
Q3
$1.74M Buy
10,429
+1,038
+11% +$175K 0.16% 64
2020
Q2
$1.53M Sell
9,391
-88
-0.9% -$15.8K 0.19% 54
2020
Q1
$1.64M Sell
9,479
-1,056
-10% -$210K 0.35% 34
2019
Q4
$2.12M Sell
10,535
-699
-6% -$143K 0.56% 24
2019
Q3
$2.37M Sell
11,234
-282
-2% -$58.9K 0.75% 16
2019
Q2
$2.23M Buy
11,516
+4,798
+71% +$885K 0.79% 17
2019
Q1
$1.11M Sell
6,718
-3,410
-34% -$603K 0.56% 43
2018
Q4
$1.91M Sell
10,128
-1,901
-16% -$351K 1.14% 16
2018
Q3
$2.05M Sell
12,029
-1,136
-9% -$191K 1.17% 20
2018
Q2
$2.16M Buy
+13,165
New +$2.15M 1.15% 21

Other funds holding CME

CSat Investment Advisory's CME Position: Q1 2021 in Review

CSat Investment Advisory increased its CME Group (CME) stake by 4% in Q1 2021, buying an estimated $394 and bringing the position to 52 shares worth $11K. The position accounts for 0.01% of the portfolio, ranked #437.

CSat Investment Advisory first reported a position in CME in Q2 2018 and has held it in 12 quarters since. The position peaked at $2.37M in Q3 2019. 1,063 funds tracked by Wall St. Rank hold CME as of Q1 2021.

  • CSat Investment Advisory held 52 shares of CME Group worth $11K as of Q1 2021.
  • CSat Investment Advisory bought 2 CME Group shares in Q1 2021, an estimated $394.
  • CME Group made up 0.01% of CSat Investment Advisory's portfolio in Q1 2021, its #437 holding.
  • CSat Investment Advisory first reported a position in CME Group in Q2 2018 and has held it in 12 quarters since.
  • CSat Investment Advisory's CME Group position peaked at $2.37M in Q3 2019.
  • 1,063 funds tracked by Wall St. Rank held CME Group as of Q1 2021.

Based on CSat Investment Advisory's 13F filing for Q1 2021, filed 13 May 2021.